The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.


Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Trump Weighs Renewed Military Action Against Iran Amid Strait of Hormuz Crisis
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Delcy Rodriguez Appears at ICJ Hearing Over Venezuela-Guyana Esequibo Dispute
Israeli Strikes in Gaza Kill Three Amid Fragile Ceasefire Tensions
Why the future of marijuana legalization remains hazy despite high public support
Iran Military Readiness Intensifies After Meeting With Mojtaba Khamenei
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Trump Nominates Cameron Hamilton to Lead FEMA After Previous Ouster
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
The four types of dementia most people don’t know exist 



